Home
Scan
Ask
Protocols
Profile
HomeIngredientsMelatonin
Reviewed by the Scan Dose Research Team and Clinical Advisory Board

Melatonin

STRONG EVIDENCESupplementLast updated April 5, 2026

SCAN DOSE SUMMARY

Melatonin is a hormone your brain naturally produces to regulate sleep-wake cycles. Our research, from 30 RCTs, 11 meta-analyses, and 13,394 participants, confirms it reliably improves insomnia symptoms and sleep quality. It's non-addictive, has low toxicity (1,000mg/day for a month showed no toxicity), and is one of the safest sleep aids available. Key insight: more is NOT better — benefits are not dose-dependent. Start low (300μg) and increase only as needed.

EVIDENCE GRADES

Insomnia Signs & SymptomsStrong — 4 studies, 259 participants, large improvement
A
Dysmenorrhea (period pain)Strong
A
Sleep QualityModerate — multiple studies
B
Blood PressureModerate — 3 studies
B
TNF-Alpha (inflammation)Moderate
B
Total Antioxidant CapacityModerate
B
Exercise performance
Recently upgraded — small improvement in power output

WHAT IT DOES

  • Reliably improves insomnia — Grade A evidence. The primary, well-proven benefit.
  • Improves sleep quality — Grade B evidence. Modest improvement in overall sleep quality scores.
  • Reduces sleep latency — Falls asleep faster. Consistent across studies.
  • Non-addictive — Unlike benzodiazepines and Z-drugs, melatonin does not cause dependency.
  • Antioxidant and anti-inflammatory effects — Grade B evidence for TNF-alpha and antioxidant capacity.
  • May reduce blood pressure — Grade B evidence with controlled-release formulation.

OPTIMAL DOSAGE

  • Starting dose: 300 μg (0.3mg) — this is physiological and effective for many people
  • Effective range: 300 μg to 5mg
  • Maximum studied without toxicity: 1,000mg/day for 1 month (do NOT do this — just shows safety margin)
  • Timing: 30 minutes before bed. Some people benefit from 1-3 hours earlier.
  • Best form: Immediate release for sleep onset. Controlled/extended release for sleep maintenance (staying asleep).
  • NOT dose-dependent: Taking more does NOT help you fall asleep faster. 0.3mg may work as well as 5mg.
Scan a supplement containing Melatonin

DRUG INTERACTIONS

WarfarinSevere

Increases INR/bleeding risk

Monitor INR closely if combining.

Sedative drugs (benzodiazepines, Z-drugs, opioids)Moderate

Additive sedation

Use caution, especially when driving next day.

CYP1A2 inducer drugs (carbamazepine, rifampin)Moderate

Reduces melatonin levels

May need higher dose.

CYP1A2 inhibitor drugs (fluvoxamine, ciprofloxacin)Moderate

Increases melatonin levels

Use lower dose.

TobaccoModerate

Reduces melatonin levels

Smokers may need higher doses.

Fluvoxamine (SSRI)Moderate

Significantly increases melatonin

Reduce melatonin dose significantly.

NifedipineModerate

Reduces drug effectiveness

Monitor BP.

CaffeineUnknown

Increases melatonin levels

Avoid caffeine close to bedtime regardless.

Blood-thinning drugsUnknown

Unclear effect on clotting

Monitor if on anticoagulants.

Blood-glucose-lowering drugsUnknown

Possible glucose effects

Monitor blood glucose if diabetic.

BP-lowering drugsMinor

Additive nighttime BP reduction

Monitor. Usually benign.

SAFETY PROFILE

Side Effects

  • Common: Drowsiness (next day too), headache, nausea, dizziness, abnormal/vivid dreams, nightmares
  • Less common: Insomnia (paradoxically), GI symptoms, reduced body temperature, mood changes (anxiety, low mood, tearfulness — rare)
  • Infrequent: Respiratory infections, muscle aches, skin pigmentation changes
  • No clear dose-response for side effects — occurs across dose ranges and formulations
  • Low toxicity profile — no signs of toxicity at 1,000mg/day for 1 month

Drug Interactions

Precautions

  • Pregnancy: Avoid. Not adequately studied. Melatonin crosses the placenta and may influence fetal development.
  • Breastfeeding: Avoid. Insufficient safety data.
  • Children: Used clinically for pediatric insomnia, but should be under medical supervision.
  • Autoimmune conditions: Melatonin is immunomodulatory. Theoretical concern about worsening autoimmune conditions.

Quality Concerns

Major issue. Canadian study: only 9 of 31 tested supplements were within 10% of labeled melatonin. Content ranged from 83% less to 478% more. 8 supplements contained serotonin (undeclared). This is a serious quality control problem.

WADA Status

Not Prohibited.

WHO SHOULD BE CAREFUL

QUALITY CONCERNS

Major issue. Canadian study: only 9 of 31 tested supplements were within 10% of labeled melatonin. Content ranged from 83% less to 478% more. 8 supplements contained serotonin (undeclared). This is a serious quality control problem.

HOW SCAN DOSE SCORES THIS

Present at 0.3-5mg:✅ Green flag — effective, well-studied dose range
Present above 10mg:⚠️ Yellow flag — no additional benefit, more side effects
In a proprietary blend:⚠️ Yellow flag — dose matters significantly
Combined with other sedative ingredients:⚠️ Yellow flag — additive drowsiness risk
Quality/content concerns:⚠️ Yellow flag — melatonin supplements frequently mislabeled. Third-party testing essential.

CLINICAL REFERENCES

1.

Melatonin significantly improved sleep quality, sleep onset latency, and total sleep time across diverse populations.

Fatemeh G et al. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis.. J Neurol (2022). PMID: 34923799

2.

Melatonin improved sleep quality in secondary sleep disorders (medical conditions causing insomnia).

Li T et al. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.. Front Neuroendocrinol (2019). PMID: 30215696

3.

71% of tested melatonin supplements did not meet label claims (±10%). Serotonin contamination found in 26%.

Erland LA et al. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.. J Clin Sleep Med (2017). PMID: 28460563

4.

Melatonin improves sleep onset latency and total sleep time in primary insomnia.

Auld F et al. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders.. Sleep Med Rev (2017). PMID: 31722088

RELATED RESEARCH

Acacia Fiber
Activated Charcoal
Agave Inulin
Agmatine SulfateReduced neuropathic pain by 46.1%

Quality Testing Intelligence

Based on independent third-party laboratory analysis

Category pass rate: ~85% pass rate. Primary issue: massive dose variation (up to 478% between highest/lowest variance products). Gummies tend to have higher variance than pills.

Common failures:
Dose inconsistency: Products ranged from 80% to 478% of labeled amount
Gummies less accurate: Higher variance in gummy formulations
Serotonin contamination: Some melatonin supplements found to contain undeclared serotonin (external study)

Melatonin reduces time to fall asleep by 12-17 minutes only (not hours); Does NOT improve sleep quality or total sleep time; Lower doses (0.3-1mg) are as effective as higher doses for sleep onset; Higher doses are NOT more effective — they just increase side effects

Scan Your Melatonin SupplementBrowse all ingredients

Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated: April 5, 2026

Not medical advice. Based on published clinical research and systematic reviews.

Safety

Melatonin: Drug Interactions

Use with caution

Moderate interactions. Monitoring, timing separation, or dose adjustment may be required.

  • Warfarin and other anticoagulants

    Melatonin may enhance anticoagulant effect.

    RiskIncreased bleeding risk.
    ActionMonitor INR.

    Source: Case reports

  • Immunosuppressants

    Melatonin stimulates immune function.

    RiskMay counteract immunosuppression.
    ActionAvoid in transplant patients.

    Source: Clinical pharmacology

  • Diabetes medications

    Melatonin may affect glucose metabolism.

    RiskBlood sugar changes.
    ActionMonitor glucose.

    Source: Clinical consensus

  • Sedatives and benzodiazepines

    Additive CNS depression.

    RiskExcessive sedation.
    ActionUse lower doses of both.

    Source: Clinical consensus

  • Fluvoxamine (Luvox)

    Fluvoxamine inhibits CYP1A2, dramatically increasing melatonin levels.

    RiskExcessive sedation and vivid dreams.
    ActionReduce melatonin dose to 0.5mg or avoid.

    Source: Clinical pharmacology

Educational information only. This is not medical advice. These statements have not been evaluated by the FDA. Talk to your prescriber before starting, stopping, or combining any supplement with prescription medication.

Discover More

Helps With
Sleep Insomnia
Related Ingredients
MagnesiumL-TheanineGlycine
Explore
Browse All 538 IngredientsBrowse All 20 Conditions